Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Excess mortality from breast cancer in female breast cancer patients with severe mental illness.

Ahlgrén-Rimpiläinen AJ, Arffman M, Suvisaari J, Manderbacka K, Lumme S, Keskimäki I, Huovinen R, Pukkala E.

Psychiatry Res. 2020 Jan 27:112801. doi: 10.1016/j.psychres.2020.112801. [Epub ahead of print]

PMID:
32001004
2.

Association of Income With the Incidence Rates of First Psychiatric Hospital Admissions in Finland, 1996-2014.

Suokas K, Koivisto AM, Hakulinen C, Kaltiala R, Sund R, Lumme S, Kampman O, Pirkola S.

JAMA Psychiatry. 2019 Dec 18. doi: 10.1001/jamapsychiatry.2019.3647. [Epub ahead of print]

PMID:
31851325
3.

Employment Status and Personal Income Before and After Onset of a Severe Mental Disorder: A Case-Control Study.

Hakulinen C, Elovainio M, Arffman M, Lumme S, Suokas K, Pirkola S, Keskimäki I, Manderbacka K, Böckerman P.

Psychiatr Serv. 2019 Nov 14:appips201900239. doi: 10.1176/appi.ps.201900239. [Epub ahead of print]

PMID:
31722646
5.

The impact of severe mental illness on lung cancer mortality of patients with lung cancer in Finland in 1990-2013: a register-based cohort study.

Arffman M, Manderbacka K, Suvisaari J, Koivunen J, Lumme S, Keskimäki I, Ahlgren-Rimpiläinen A, Pukkala E.

Eur J Cancer. 2019 Sep;118:105-111. doi: 10.1016/j.ejca.2019.06.018. Epub 2019 Jul 19.

PMID:
31326729
6.

Mental disorders and long-term labour market outcomes: nationwide cohort study of 2 055 720 individuals.

Hakulinen C, Elovainio M, Arffman M, Lumme S, Pirkola S, Keskimäki I, Manderbacka K, Böckerman P.

Acta Psychiatr Scand. 2019 Oct;140(4):371-381. doi: 10.1111/acps.13067. Epub 2019 Aug 26.

PMID:
31254386
7.

Health information exchange in Finland: Usage of different access types and predictors of paper use.

Hyppönen H, Lumme S, Reponen J, Vänskä J, Kaipio J, Heponiemi T, Lääveri T.

Int J Med Inform. 2019 Feb;122:1-6. doi: 10.1016/j.ijmedinf.2018.11.005. Epub 2018 Nov 23.

PMID:
30623778
8.

Trends of socioeconomic equality in mortality amenable to healthcare and health policy in 1992-2013 in Finland: a population-based register study.

Lumme S, Manderbacka K, Karvonen S, Keskimäki I.

BMJ Open. 2018 Dec 18;8(12):e023680. doi: 10.1136/bmjopen-2018-023680.

9.

The effect of history of severe mental illness on mortality in colorectal cancer cases: a register-based cohort study.

Manderbacka K, Arffman M, Lumme S, Suvisaari J, Keskimäki I, Ahlgren-Rimpiläinen A, Malila N, Pukkala E.

Acta Oncol. 2018 Jun;57(6):759-764. doi: 10.1080/0284186X.2018.1429649. Epub 2018 Jan 24.

PMID:
29363989
10.

Effect of stage, comorbidities and treatment on survival among cancer patients with or without mental illness.

Manderbacka K, Arffman M, Suvisaari J, Ahlgren-Rimpiläinen A, Lumme S, Keskimäki I, Pukkala E.

Br J Psychiatry. 2017 Nov;211(5):304-309. doi: 10.1192/bjp.bp.117.198952. Epub 2017 Sep 21.

PMID:
28935659
11.

Trends of relative and absolute socioeconomic equity in access to coronary revascularisations in 1995-2010 in Finland: a register study.

Lumme S, Manderbacka K, Keskimäki I.

Int J Equity Health. 2017 Feb 20;16(1):37. doi: 10.1186/s12939-017-0536-8.

12.

Regional trends in avoidable hospitalisations due to complications among population with diabetes in Finland in 1996-2011: a register-based cohort study.

Manderbacka K, Arffman M, Lumme S, Lehikoinen M, Winell K, Keskimäki I.

BMJ Open. 2016 Aug 22;6(8):e011620. doi: 10.1136/bmjopen-2016-011620.

13.

Excess Mortality in Patients with Severe Mental Disorders in 1996-2010 in Finland.

Lumme S, Pirkola S, Manderbacka K, Keskimäki I.

PLoS One. 2016 Mar 24;11(3):e0152223. doi: 10.1371/journal.pone.0152223. eCollection 2016.

14.

Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer.

Lumme S, Tenkanen L, Langseth H, Gislefoss R, Hakama M, Stattin P, Hallmans G, Adlercreutz H, Saikku P, Stenman UH, Tuohimaa P, Luostarinen T, Dillner J.

Acta Oncol. 2016 Jul;55(7):839-45. doi: 10.3109/0284186X.2016.1139178. Epub 2016 Feb 15.

PMID:
26878091
15.

A Monte Carlo method to estimate the confidence intervals for the concentration index using aggregated population register data.

Lumme S, Sund R, Leyland AH, Keskimäki I.

Health Serv Outcomes Res Methodol. 2015;15(2):82-98. Epub 2015 Feb 18.

16.

Are there socioeconomic differences in outcomes of coronary revascularizations--a register-based cohort study.

Manderbacka K, Arffman M, Lumme S, Keskimäki I.

Eur J Public Health. 2015 Dec;25(6):984-9. doi: 10.1093/eurpub/ckv086. Epub 2015 May 9.

PMID:
25958240
17.

The contribution of health policy and care to income differences in life expectancy--a register based cohort study.

Manderbacka K, Peltonen R, Lumme S, Keskimäki I, Tarkiainen L, Martikainen P.

BMC Public Health. 2013 Sep 8;13:812. doi: 10.1186/1471-2458-13-812.

18.

Socioeconomic equity in amenable mortality in Finland 1992-2008.

Lumme S, Sund R, Leyland AH, Keskimäki I.

Soc Sci Med. 2012 Sep;75(5):905-13. doi: 10.1016/j.socscimed.2012.04.007. Epub 2012 May 9.

PMID:
22647563
19.

Multilevel modeling of regional variation in equity in health care.

Lumme S, Leyland AH, Keskimäki I.

Med Care. 2008 Sep;46(9):976-83. doi: 10.1097/MLR.0b013e3181791970.

PMID:
18725853
20.

Transduction patterns and efficiencies in rabbit uterine tissues after intraluminal uterine adenovirus administration vary with the reproductive cycle.

Laurema A, Lumme S, Heinonen SE, Heinonen S, Ylä-Herttuala S.

Acta Obstet Gynecol Scand. 2007;86(9):1035-40.

PMID:
17712641
21.

Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer.

Tuohimaa P, Tenkanen L, Syvälä H, Lumme S, Hakulinen T, Dillner J, Hakama M.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):302-7.

22.

Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study.

Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, Hakulinen T, Stattin P, Luostarinen T, Lehtinen M, Hakama M.

Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2952-5.

23.

Chlamydial antibodies and risk of prostate cancer.

Anttila T, Tenkanen L, Lumme S, Leinonen M, Gislefoss RE, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Stattin P, Saikku P, Dillner J, Lehtinen M, Hakama M.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):385-9.

24.

High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.

Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M.

Int J Cancer. 2004 Jan 20;108(3):418-24.

25.

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.

Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M.

Int J Cancer. 2004 Jan 1;108(1):104-8.

26.

Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.

Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M.

Int J Cancer. 2002 May 1;99(1):124-9.

Supplemental Content

Support Center